Company
A new era for human health
Welcome to our Canadian website. GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.
A signal for change
1:48
Our strategy
We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies.
Our R&D focus is on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.
$3 mil +
contributed over the last 20 years to support the hospice palliative care movement in Canada
GSK Global links
Visit our Global site for additional features
Press releases
- Jemperli (dostarlimab for injection) plus carboplatin and paclitaxel approved in Canada as a treatment option for primary advanced or recurrent dMMR/MSI-H endometrial cancer
- GSK announces largest private financial contribution to CIHR’s Team Grants initiative addressing threats to Canadian lung health
- GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for older adults approved in Canada
Choose your path
By bringing outstanding people together in an inclusive environment to do work that matters, we can impact the world’s health.
